Grupo Lamosa, S.A.B. de C.V. (BMV:LAMOSA)

Market Cap	38.97B
Revenue (ttm)	35.08B
Net Income (ttm)	396.93M
Shares Out	341.88M
EPS (ttm)	1.15
PE Ratio	98.79
Forward PE	17.06
Dividend	2.00 (1.75%)
Ex-Dividend Date	Apr 8, 2025

Volume	23
Average Volume	13,096
Open	114.00
Previous Close	114.00
Day's Range	114.00 - 114.00
52-Week Range	109.00 - 121.00
Beta	0.10
RSI	55.13
Earnings Date	Jul 25, 2025

About Intercept Pharmaceuticals

Grupo Lamosa, S.A.B. de C.V., together with its subsidiaries, engages in the design, manufacture, and distribution of ceramic and porcelain products for floor and wall coverings, and adhesive for coatings in North America, Central America, South America, and Europe. The company operates through Coatings and Adhesives and Insulators segments. It offers floors and wall tiles; and adhesives for floors and walls, grouting agents, jointers, stuccos, additives, waterproofing, and specialized materials. The company was founded in 1890 and is based in ...

• Industry: Building Products & Equipment
• Sector: Industrials
• Founded: 1890
• Employees: 10,829
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: LAMOSA

Financial Performance

In 2024, Grupo Lamosa's revenue was 33.95 billion, an increase of 7.52% compared to the previous year's 31.57 billion. Earnings were 131.33 million, a decrease of -95.96%.